当前位置:首页 / 天冬氨酸氨基转移酶/丙氨酸氨基转移酶比值与射血分数保留心力衰竭患者预后的相关性研究▲
论著 | 更新时间:2023-07-06
|
天冬氨酸氨基转移酶/丙氨酸氨基转移酶比值与射血分数保留心力衰竭患者预后的相关性研究▲
Correlation study between the aspartate aminotransferase to alanine aminotransferase ratio and the prognosis of patients with heart failure with preserved ejection fraction

微创医学 20231803期 页码:294-299

作者机构:广西医科大学第一附属医院,广西南宁市530021

基金信息:▲基金项目:中国博士后科学基金(编号:2021MD703817)*通信作者

DOI:DOI:10.11864/j.issn.1673.2023.03.05

  • 中文简介
  • 英文简介
  • 参考文献
目的探讨天冬氨酸氨基转移酶/丙氨酸氨基转移酶比值(AAR)与入住重症监护病房(ICU)的射血分数保留心力衰竭(HFpEF)患者长期预后的关系。方法选取MIMIC-Ⅲ数据库中于2001~2012年入住ICU的HFpEF患者进行分析,共入组1 228例HFpEF患者,通过X-tile软件,以AAR最佳截断值分为高AAR组(AAR≥1.42)和低AAR组(AAR<1.42),比较两组患者的临床资料;以入住ICU后1年全因死亡为终点事件绘制Kaplan-Meier生存曲线,使用Cox比例风险回归模型分析HFpEF患者AAR与入住ICU后1年全因死亡率之间的相关性。结果高AAR组患者的年龄,合并慢性阻塞性肺疾病、甲状腺功能减退、房颤/房扑的比例及血清肌酐水平高于低AAR组,体重、BMI、收缩压、血红蛋白水平、使用利尿剂的比例低于低AAR组,差异均有统计学意义(均P<0.05)。Log-Rank检验结果显示高AAR组HFpEF患者的生存率低于AAR组,差异有统计学意义(P<0.05)。Cox多因素分析结果显示,AAR、年龄、BMI、收缩压、使用利尿剂是HFpEF患者入住ICU之日起1年内全因死亡的独立影响因素(均P<0.05)。结论临床应根据HFpEF患者入住ICU后1年内全因死亡的独立影响因素进行有针对性的治疗干预,以降低患者死亡率。
ObjectiveTo investigate the correlation between the aspartate aminotransferase to alanine aminotransferase ratio (AAR) and the long-term prognosis of patients with heart failure with preserved ejection fraction (HFpEF) who are admitted to the intensive care unit (ICU). MethodsA total of 1 228 HFpEF patients admitted to the ICU from 2001 to 2012 were included in the analysis from the MIMIC-Ⅲ database. According to the optimal cut-off value of AAR, the patients were divided into a high AAR group (AAR ≥1.42) and a low AAR group (AAR<1.42) by the X-tile software, and the clinical data between the two groups were compared. A Kaplan-Meier survival curve was plotted with 1-year all-cause mortality after ICU admission as the endpoint event, and a Cox proportional hazard regression model was used to analyze the correlation between AAR and 1-year all-cause mortality after ICU admission in HFpEF patients. ResultsCompared to the low AAR group, the high AAR group had higher age, proportions of patients with chronic obstructive pulmonary disease, hypothyroidism and atrial fibrillation/atrial flutter, and serum creatinine level,as well as lower body weight, BMI, systolic blood pressure, hemoglobin level and proportion of diuretic use, with statistically significant differences (all P<0.05). The result of Log-Rank test showed that the survival rate of HFpEF patients in the high AAR group was lower than that of the low AAR group, with statistically significant difference (P<0.05). The result of Cox multivariate analysis showed that AAR, age, BMI, systolic blood pressure, and use of diuretic were independent influencing factors for all-cause mortality within 1-year from the day of ICU admission in HFpEF patients (all P<0.05). ConclusionIn order to reduce the mortality of HFpEF patients, targeted therapeutic intervention should be carried out according to the independent factors of 1-year all-cause mortality after ICU admission.

1395

浏览量

343

下载量

0

CSCD

工具集